We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Michael Weber, MD
M. Luiza Caramori, MD, PhD, MSc
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Peter Rossing, MD, DMSc
Establishing a Best Practice Between Primary Care and Specialists
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
Kelly Chenlei Li, MBBS, FRACP
Paul Bennett, RN, MHSM, PhD, FISN
Thilo Krüger, MD, PhD
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Jurgen Floege MD
Uyen Huynh-Do, MD
TRANSFORMing Cardiovascular Care
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Marc P. Bonaca, MD, MPH
Matthew Jay Budoff, MD
David J. Maron, MD
Pam R. Taub, MD, FACC, FASPC
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Staging Coronary Risk: A New TRANSFORMative Approach
TRANSFORM Trial: Overview and Potential Implications
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
Joel Topf, MD
James Burton, DM, FRCP
Curbside Consult: Optimizing IgAN Management
Khalil El Karoui, MD
Federico Alberici, MD, PhD
Overcoming Clinical Inertia in Hyperkalemia Management
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
The Future of ADH1 - Looking at Emergent Treatments
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education